Environmental variables associated with an increased risk of invasive aspergillosis

Clinical Microbiology and Infection

Volumn 20, Issue 11, 2014, Pages O939-O945

  Garcia Vidal, C ^a,b   Royo Cebrecos, C ^a   Peghin, M ^c   Moreno, A ^d   Ruiz Camps, I ^c   Cervera, C ^d   Belmonte, J ^e   Gudiol, C ^a,b   Labori, M ^a   Rosello E ^c   de la Bellacasa, J Puig ^d   Ayats, J ^a   Carratala J ^a,b  

^a HOSPITAL UNIVERSITARI DE BELLVITGE   (Spain)

^b REIPI (Spanish Network for Research in Infectious Diseases)   (Spain)

^c HOSPITAL UNIVERSITARI VALL D HEBRON   (Spain)

^d UNIVERSITY OF BARCELONA   (Spain)

^e INSTITUT DE CIÈNCIA I TECNOLOGIA AMBIENTALS   (Spain)

Author keywords

Airborne mould counts; Climatic conditions; Environmental variables; Invasive aspergillosis; Respiratory viruses

Indexed keywords

ANTIGEN; GALACTOMANNAN ANTIGEN; UNCLASSIFIED DRUG;

ADENOVIRIDAE; ADULT; AGED; AIRBORNE FUNGUS; ARTICLE; CLIMATE; DISEASE ASSOCIATION; ENVIRONMENTAL FACTOR; FEMALE; FUNGUS CULTURE; FUNGUS SPORE; GENETIC ASSOCIATION; HISTOLOGY; HUMAN; HUMAN RESPIRATORY SYNCYTIAL VIRUS; INFECTION RISK; INFLUENZA VIRUS A H1N1; INVASIVE ASPERGILLOSIS; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; NEOPLASM; NEUTROPENIA; NONHUMAN; PRIORITY JOURNAL; RETROSPECTIVE STUDY; BACTERIAL COUNT; CLINICAL TRIAL; COHORT ANALYSIS; INCIDENCE; INVASIVE PULMONARY ASPERGILLOSIS; ISOLATION AND PURIFICATION; MICROBIOLOGY; MIDDLE AGED; RISK ASSESSMENT; SPAIN; VIRUS;

ADENOVIRIDAE; RESPIRATORY SYNCYTIAL VIRUS;

ADENOVIRIDAE; AGED; AIR MICROBIOLOGY; CLIMATE; COHORT STUDIES; COLONY COUNT, MICROBIAL; FEMALE; HUMANS; INCIDENCE; INVASIVE PULMONARY ASPERGILLOSIS; MALE; MIDDLE AGED; RESPIRATORY SYNCYTIAL VIRUSES; RETROSPECTIVE STUDIES; RISK ASSESSMENT; SPAIN; SPORES, FUNGAL; VIRUSES;

EID: 84917734220     PISSN: 1198743X     EISSN: 14690691     Source Type: Journal    
DOI: 10.1111/1469-0691.12650     Document Type: Article

References (17)

1. Upton A, Kirby KA, Carpenter P, Boeckh M, Marr K. Invasive aspergillosis following hematopoietic cell transplantation: outcomes and prognostic factors associated with mortality. Clin Infect Dis 2007; 44: 531-540.
2. Neofytos D, Treadway S, Ostrander D et al. Epidemiology, outcomes, and mortality predictors of invasive mold infections among transplant recipients: a 10-year, single-center experience. Transpl Infect Dis 2013; 15: 233-242.
3. Garcia-Vidal C, Viasus D, Carratalà J. Pathogenesis of invasive fungal infections. Curr Opin Infect Dis 2013; 26: 270-276.
4. Segal B. Aspergillosis. N Engl J Med 2009; 360: 1870-1884.
5. Garcia-Vidal C, Upton A, Kirby K et al. Epidemiology of invasive mould infections in allogenic stem cell transplant recipients: biological risk factors for infection according to time after transplant. Clin Infect Dis 2008; 47: 1041-1050.
6. Kontoyiannis DP, Marr KA, Park BJ et al. Prospective surveillance for invasive fungal infections in hematopoietic stem cell transplant recipients, 2001-2006: overview of the transplant-associated infection surveillance network (TRANSNET) database. Clin Infect Dis 2010; 50: 1091-1100.
7. Gavalda J, Len O, San Juan R et al. Risk factors for invasive aspergillosis in solid-organ transplant recipients: a case-control study. Clin Infect Dis 2005; 41: 52-59.
8. Panackal AA, Li H, Kontoyiannis DP et al. Geoclimatic influences on invasive aspergillosis after hematopoietic stem cell transplantation. Clin Infect Dis 2010; 50: 1588-1597.
9. Pauw B, Walsh TJ, Donnelly JP, Stevens DA, Edwards JE, Calandra T, and the European Organization for Research and Treatment of Cancer/Invasive Fungal Infections Cooperative Group; National Institute of Allergy and Infectious Diseases Mycoses Study Group (EORTC/MSG) Consensus Group. Revised definitions of invasive fungal disease from the European Organization for Research and Treatment of Cancer/Invasive Fungal Infections Cooperative Group and the National Institute of Allergy and Infectious Diseases Mycoses Study Group (EORTC/MSG) Consensus Group. Clin Infect Dis 2008; 46: 1813-1821.
10. Warris A, Verweij PE. Clinical implications of environmental sources for Aspergillus. Med Mycol 2005; 43(Suppl 1): 59-65.
11. Paul M. Seasonality in infectious diseases: does it exist for all pathogens? Clin Microbiol Infect 2012; 18: 925-926.
12. Garcia-Vidal C, Labori M, Viasus D et al. Rainfall is a risk factor for sporadic cases of Legionella pneumophila pneumonia. PLoS One 2013; 8: e61036.
13. Marr KA, Carter RA, Boeckh M, Martin P, Corey L. Invasive aspergillosis in allogeneic stem cell transplant recipients: changes in epidemiology and risk factors. Blood 2002; 100: 4358-4366.
14. Martino R, Piñana JL, Parody R et al. Lower respiratory tract respiratory virus infections increase the risk of invasive aspergillosis after a reduced-intensity allogeneic hematopoietic SCT. Bone Marrow Transplant 2009; 44: 749-756.
15. Garcia-Vidal C, Barba P, Arnan M et al. Invasive aspergillosis complicating pandemic influenza A (H1N1) infection in severely immunocompromised patients. Clin Infect Dis 2011; 53: e16-9.
16. Danzinger-Isakov L, Kumar D. Guidelines for vaccination of solid organ transplant candidates and recipients. Am J Transplant 2009; 9(suppl): 258-262.
17. Ljungman P, Cordonnier C, Einsele H et al. Vaccination of hematopoietic cell transplant recipients. Bone Marrow Transplant 2009; 44: 521-526.